Expertise

Since joining Indiana University, his research is focused on the discovery and implementation of genomic predictors of drug response. More specifically, his studies are focused on genetic variants in the ADME genes.

They also include studies to identify miRNAs that contribute to the drug-induced and developmental changes in hepatic drug metabolism.

Research: Identification of mechanisms in breast cancer cells and patients that alter their responsiveness to endocrine therapies. Dr. Skaar’s research is focused on the discovery and implementation of genomic predictors of drug response. The discovery studies include identifying genetic variants that are associated with clinical drug efficacy and toxicity


Subject Area: Medicine.


Subject area: Precision Medicine

Past Affiliations
Communities
Oncology, Pharmacology
Degrees
PhD, Pennsylvania State University, Dairy, Animal Science, 1992
MS, University of Wisconsin-Madison, Dairy Science, 1988
BS, South Dakota State University, Dairy, Animal Science, 1986
Keywords
health and medicine pharmacy & pharmacology breast cancer pharmacogenetics